Associated factors with repeat coronary angioplasty during the drug eluting stent era: a high volume center investigation

Chen LIU; Hong-bing YAN; Han-jun ZHAO; Li SONG; Bin ZHENG; Yun-peng CHI; Shao-ping WANG; Jian WANG; Hong-yu PENG; Zheng WU.
Chinese Medical Journal ; (24): 446-449, 2013.
Artículo en Inglés | WPRIM | ID: wpr-342564

Documentos relacionados

  1. Predictors of 10-Year Stent-Related Adverse Outcomes after Coronary Drug-Eluting Stent Implantation: The Importance of Stent Size.
  2. Improved Outcomes of Combined Main Branch Stenting and Side Branch Drug-Coated Balloon versus Two-Stent Strategy in Patients with Left Main Bifurcation Lesions.
  3. Spillover effects and other determinants of medical device uptake in the presence of a medical guideline: An analysis of drug-eluting stents in Germany and Italy.
  4. Comparison of long-term outcomes of double kissing crush versus T and minimal protrusion techniques in complex bifurcation lesions: The EVOLUTE-CRUSH II registry.
  5. Long-term cardiovascular outcomes of biodegradable polymer drug eluting stents in patients with diabetes versus non-diabetes mellitus: a meta-analysis.
  6. Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis.
  7. Long-term clinical outcomes after drug eluting stent implantation with and without stent overlap.
  8. Interventional cardiology, where real life and science do not necessarily meet.
  9. [Advances in Preparation and Evaluation of Non-vascular Drug-eluting Stents].
  10. [Research Progress of Biodegradable Vascular Stent].